195 related articles for article (PubMed ID: 33980253)
21. Current molecular and therapeutic advances in liposarcoma, rhabdomyosarcoma, leiomyosarcoma, synovial sarcoma, and angiosarcoma.
Tanriverdi O; Yildiz A
J Oncol Pharm Pract; 2022 Apr; 28(3):635-645. PubMed ID: 35043739
[TBL] [Abstract][Full Text] [Related]
22. Soft tissue sarcoma subtypes exhibit distinct patterns of acquired uniparental disomy.
Tuna M; Ju Z; Amos CI; Mills GB
BMC Med Genomics; 2012 Dec; 5():60. PubMed ID: 23217126
[TBL] [Abstract][Full Text] [Related]
23. Integrative DNA methylation and gene expression analysis in high-grade soft tissue sarcomas.
Renner M; Wolf T; Meyer H; Hartmann W; Penzel R; Ulrich A; Lehner B; Hovestadt V; Czwan E; Egerer G; Schmitt T; Alldinger I; Renker EK; Ehemann V; Eils R; Wardelmann E; Büttner R; Lichter P; Brors B; Schirmacher P; Mechtersheimer G
Genome Biol; 2013 Dec; 14(12):r137. PubMed ID: 24345474
[TBL] [Abstract][Full Text] [Related]
24. Loss of p16(INK4a) is associated with reduced patient survival in soft tissue tumours, and indicates a senescence barrier.
Knösel T; Altendorf-Hofmann A; Lindner L; Issels R; Hermeking H; Schuebbe G; Gibis S; Siemens H; Kampmann E; Kirchner T
J Clin Pathol; 2014 Jul; 67(7):592-8. PubMed ID: 24747207
[TBL] [Abstract][Full Text] [Related]
25. Dedifferentiated liposarcomas with divergent myosarcomatous differentiation developed in the internal trunk: a study of 27 cases and comparison to conventional dedifferentiated liposarcomas and leiomyosarcomas.
Binh MB; Guillou L; Hostein I; Château MC; Collin F; Aurias A; Binh BN; Stoeckle E; Coindre JM
Am J Surg Pathol; 2007 Oct; 31(10):1557-66. PubMed ID: 17895758
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of PLAGL1-specific CpG site methylation in soft-tissue sarcomas.
Peille AL; Brouste V; Kauffmann A; Lagarde P; Le Morvan V; Coindre JM; Chibon F; Bresson-Bepoldin L
PLoS One; 2013; 8(11):e80741. PubMed ID: 24260468
[TBL] [Abstract][Full Text] [Related]
27. MET gene copy number alterations and expression of MET and hepatocyte growth factor are potential biomarkers in angiosarcomas and undifferentiated pleomorphic sarcomas.
Schmitz K; Koeppen H; Binot E; Fassunke J; Künstlinger H; Ihle MA; Heydt C; Wardelmann E; Büttner R; Merkelbach-Bruse S; Rüschoff J; Schildhaus HU
PLoS One; 2015; 10(4):e0120079. PubMed ID: 25844809
[TBL] [Abstract][Full Text] [Related]
28. Human soft tissue sarcomas harbor an intratumoral viral microbiome which is linked with natural killer cell infiltrate and prognosis.
Perry LM; Cruz SM; Kleber KT; Judge SJ; Darrow MA; Jones LB; Basmaci UN; Joshi N; Settles ML; Durbin-Johnson BP; Gingrich AA; Monjazeb AM; Carr-Ascher J; Thorpe SW; Murphy WJ; Eisen JA; Canter RJ
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36599469
[TBL] [Abstract][Full Text] [Related]
29. Soft tissue sarcomas with complex genomic profiles.
Guillou L; Aurias A
Virchows Arch; 2010 Feb; 456(2):201-17. PubMed ID: 20217954
[TBL] [Abstract][Full Text] [Related]
30. Undifferentiated and dedifferentiated soft tissue neoplasms: Immunohistochemical surrogates for differential diagnosis.
Thway K; Fisher C
Semin Diagn Pathol; 2021 Nov; 38(6):170-186. PubMed ID: 34602314
[TBL] [Abstract][Full Text] [Related]
31. DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcoma.
Koelsche C; Kriegsmann M; Kommoss FKF; Stichel D; Kriegsmann K; Vokuhl C; Grünewald TGP; Romero-Pérez L; Kirchner T; de Alava E; Diaz-Martin J; Hartmann W; Baumhoer D; Antonescu CR; Szuhai K; Flucke U; Dirksen U; Pfister SM; Jones DTW; Mechtersheimer G; von Deimling A
J Cancer Res Clin Oncol; 2019 May; 145(5):1273-1281. PubMed ID: 30895378
[TBL] [Abstract][Full Text] [Related]
32. Periostin and Epithelial-Mesenchymal Transition Score as Novel Prognostic Markers for Leiomyosarcoma, Myxofibrosarcoma, and Undifferentiated Pleomorphic Sarcoma.
Piano MA; Brunello A; Cappellesso R; Del Bianco P; Mattiolo A; Fritegotto C; Montini B; Zamuner C; Del Fiore P; Rastrelli M; Sommariva A; De Salvo GL; Montesco MC; Rossi CR; Zagonel V; Calabrò ML
Clin Cancer Res; 2020 Jun; 26(12):2921-2931. PubMed ID: 32127392
[TBL] [Abstract][Full Text] [Related]
33. Current Concepts in Non-Gastrointestinal Stromal Tumor Soft Tissue Sarcomas: A Primer for Radiologists.
Baheti AD; Jagannathan JP; O'Neill A; Tirumani H; Tirumani SH
Korean J Radiol; 2017; 18(1):94-106. PubMed ID: 28096721
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for lymph node metastasis of soft tissue sarcomas of the head, neck, and extremities, and the clinical significance of negative lymph node dissection.
Liu QK; Yu XJ; Wang YG; Lu R; Wang SX; Xu HR; Kang H
J Orthop Surg Res; 2022 Mar; 17(1):167. PubMed ID: 35303897
[TBL] [Abstract][Full Text] [Related]
35. Tumor morphology and location associate with immune cell composition in pleomorphic sarcoma.
Wustrack RL; Shao E; Sheridan J; Zimel M; Cho SJ; Horvai AE; Luong D; Kwek SS; Fong L; Okimoto RA
Cancer Immunol Immunother; 2021 Oct; 70(10):3031-3040. PubMed ID: 33864502
[TBL] [Abstract][Full Text] [Related]
36. Lessons from genetic profiling in soft tissue sarcomas.
Nilbert M; Meza-Zepeda LA; Francis P; Berner JM; Namløs HM; Fernebro J; Myklebost O
Acta Orthop Scand Suppl; 2004 Apr; 75(311):35-50. PubMed ID: 15188664
[TBL] [Abstract][Full Text] [Related]
37. Dual Pten/Tp53 suppression promotes sarcoma progression by activating Notch signaling.
Guijarro MV; Dahiya S; Danielson LS; Segura MF; Vales-Lara FM; Menendez S; Popiolek D; Mittal K; Wei JJ; Zavadil J; Cordon-Cardo C; Pandolfi PP; Hernando E
Am J Pathol; 2013 Jun; 182(6):2015-27. PubMed ID: 23708211
[TBL] [Abstract][Full Text] [Related]
38. PD-L1 (CD274) copy number gain, expression, and immune cell infiltration as candidate predictors for response to immune checkpoint inhibitors in soft-tissue sarcoma.
Budczies J; Mechtersheimer G; Denkert C; Klauschen F; Mughal SS; Chudasama P; Bockmayr M; Jöhrens K; Endris V; Lier A; Lasitschka F; Penzel R; Dietel M; Brors B; Gröschel S; Glimm H; Schirmacher P; Renner M; Fröhling S; Stenzinger A
Oncoimmunology; 2017; 6(3):e1279777. PubMed ID: 28405504
[TBL] [Abstract][Full Text] [Related]
39. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
[TBL] [Abstract][Full Text] [Related]
40. Establishment and Characterization of Histologically and Molecularly Stable Soft-tissue Sarcoma Xenograft Models for Biological Studies and Preclinical Drug Testing.
Cornillie J; Wozniak A; Li H; Wang Y; Boeckx B; Gebreyohannes YK; Wellens J; Vanleeuw U; Hompes D; Stas M; Sinnaeve F; Wafa H; Lambrechts D; Debiec-Rychter M; Sciot R; Schöffski P
Mol Cancer Ther; 2019 Jun; 18(6):1168-1178. PubMed ID: 30962320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
